Evercore ISI raised the firm’s price target on CVS Health (CVS) to $105 from $100 and keeps an Outperform rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVS:
- CVS Health price target raised to $101 from $93 at Barclays
- CVS Health price target raised to $100 from $95 at BofA
- CVS Health price target raised to $100 from $97 at UBS
- CVS Health reports Q1 adjusted EPS $2.57, consensus $2.21
- CVS Health raises FY26 adjusted EPS view to $7.30-$7.50 from $7.00-$7.20